Drug application
LUPANETA PACK (LEUPROLIDE ACETATE, NORETHINDRONE ACETATE)
Drugs@FDA NDA 203696 · ABBVIE ENDOCRINE
Key facts
| Drug name | LUPANETA PACK |
|---|---|
| Active ingredients | LEUPROLIDE ACETATE, NORETHINDRONE ACETATE |
| Application type | NDA |
| Application number | 203696 |
| Company | ABBVIE ENDOCRINE |
| Dosage forms | INJECTABLE, TABLET, INTRAMUSCULAR, ORAL |
| Strength | 3.75MG/VIAL,N/A;N/A,5MG |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Dec 14, 2012 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: